Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Budesonide Therapy for COVID-19 Related Hyposmia
NCT04361474Phase 3Completed
- Sponsor
- Adolphe de Rothschild Foundation Hospital
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised trial of budesonide in Hyposmia (2 arms), sponsored by Adolphe de Rothschild Foundation Hospital. Primary endpoint: Proportion of patients with more than 2 points on the ODORATEST at 30 days. Started May 2020; status: completed.
02
Drugs
budesonide
03
Conditions
Hyposmia
Beyond the preview
Go deeper on NCT04361474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361474.